Single Dose Pharmacokinetic Study of CYCLOSET 0.8 mg Tablets Following Administration of a Weight-Adjusted Dose in Male and Female Children and Adolescent Type 2 Diabetes Mellitus Subjects VS-PEDS BA-2010-V4
Phase of Trial: Phase I
Latest Information Update: 08 Sep 2016
At a glance
- Drugs Bromocriptine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors VeroScience
- 26 Aug 2016 Status changed from recruiting to completed.
- 23 Dec 2015 Planned End Date changed from 1 Dec 2016 to 1 Jun 2016 as per ClinicalTrials.gov record.
- 23 Dec 2015 Planned primary completion date changed from 1 Dec 2016 to 1 Jun 2016 as per ClinicalTrials.gov record.